Market Cap 1.53B
Revenue (ttm) 0.00
Net Income (ttm) -161.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 260,511
Avg Vol 376,362
Day's Range N/A - N/A
Shares Out 42.62M
Stochastic %K 90%
Beta N/A
Analysts Strong Sell
Price Target $39.55

Company Profile

MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company's products include ML-007C-MA, a fixed-dose combination of an M 1 /M 4 muscarinic agonist for the treatment of schizophrenia and Alzheimer's disease psychosis; ML-004 for the treatment of social communication deficit and/or irritability in autism spectrum disorder; ML-021 for the treatment of motor deficits in Parkinson's diseas...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 984 6300
Address:
800 Chesapeake Drive, Redwood City, United States
BioRich
BioRich Jul. 1 at 4:47 PM
$NNE Stocktwits Q2 Quarterly Filing: @BioRich Top 50 portfolio positions: 1) GUTS 2) ABVX 3) IBRX 4) ALT 5) KYTX 6) DAVE 7) CADL 8) MIST 9) UEC 10) OTLK 11) CAPR 12) TGTX 13) SABS 14) NVAX 15) LEGN 16) VKTX 17) OCUL 18) SOFI 19) BBIO 20) SGP 21) VNDA 22) SHAZ 23) NRXP 24) GPCR 25) EWTX 26) TLSA 27) SKM 28) MLTX 29) SNDX 30) JMIA 31) NKTR 32) VVOS 33) RGNX 35) ARRNF 36) CRMD 37) WVE 38) NUVB 39) SMMT 40) ANNX 41) CGON 42) TEM 43) IVA 44) PSN 45) LGND 46) $IMVT 47) $MPLT 48) NNE 49) $ARDX 50) $COGT If I own it, I believe in it. What am I missing? Hold too much? Not enough? Look forward to your feedback! Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers!
0 · Reply
Duncan_
Duncan_ Jun. 30 at 3:39 PM
0 · Reply
JuggernautRaider
JuggernautRaider Jun. 27 at 7:20 AM
$MPLT hmm tell me more? $CGTX $TLSA are golden and I own a bit of $BMY … Maplight is looking good. Really good 💡
1 · Reply
Duncan_
Duncan_ Jun. 26 at 4:03 PM
$MPLT as @BioRich says "lets make some money"
0 · Reply
Duncan_
Duncan_ Jun. 26 at 1:30 PM
0 · Reply
Hopipaytrader
Hopipaytrader Jun. 26 at 1:47 AM
$MPLT hello, getting close, but now up the ante
0 · Reply
Quantumup
Quantumup Jun. 25 at 1:14 PM
Raymond James y'day🏁 $MPLT and said: We are initiating coverage of MapLight Therapeutics (MPLT) at Strong Buy with a $46 target price. $BMY OTSKY ABBV NBIX LBRX RVPH ATAI TEVA ITCI Here's what Raymond James had to say: https://x.com/Quantumup1/status/2070133195882836133?s=20
0 · Reply
ripster47
ripster47 Jun. 25 at 11:12 AM
$MPLT | Raymond James Initiates MapLight Therapeutics at Strong Buy with $46.00 PT on Pipeline Differentiation and Clinical Upside Raymond James stays bullish as ML-007C-MA differentiation and mid-stage catalysts drive strong upside outlook 🔹 Follow @tenet_research for more analyst insights on other tickers.
0 · Reply
MNYMKR2018
MNYMKR2018 Jun. 25 at 12:30 AM
$MPLT Alright I’m sold! Follower 122! Reporting for duty…😜🍻
0 · Reply
Rearview
Rearview Jun. 24 at 9:57 PM
$MPLT CFO ”separated” due to HR violation - shortly after selling 1M holding
0 · Reply
Latest News on MPLT
MapLight Therapeutics Transcript: Study result

Jun 22, 2026, 8:00 AM EDT - 10 days ago

MapLight Therapeutics Transcript: Study result


MapLight Therapeutics Press release: Study result

Jun 22, 2026, 8:00 AM EDT - 10 days ago

MapLight Therapeutics Press release: Study result


MapLight Therapeutics Slides: Study result

Jun 22, 2026, 8:00 AM EDT - 10 days ago

MapLight Therapeutics Slides: Study result


MapLight Therapeutics initiated with a Buy at UBS

2026-05-26T20:27:27.000Z - 5 weeks ago

MapLight Therapeutics initiated with a Buy at UBS


MapLight Therapeutics initiated with a Buy at Craig-Hallum

2026-05-21T11:28:49.000Z - 6 weeks ago

MapLight Therapeutics initiated with a Buy at Craig-Hallum


MapLight Therapeutics Earnings release: Q1 2026

May 14, 2026, 4:00 PM EDT - 7 weeks ago

MapLight Therapeutics Earnings release: Q1 2026


MapLight Therapeutics Quarterly report: Q1 2026

May 14, 2026, 4:00 PM EDT - 7 weeks ago

MapLight Therapeutics Quarterly report: Q1 2026


MapLight Therapeutics management to meet with Needham

2026-05-12T20:10:57.000Z - 7 weeks ago

MapLight Therapeutics management to meet with Needham


MapLight Therapeutics initiated with a Buy at H.C. Wainwright

2026-05-04T10:16:54.000Z - 2 months ago

MapLight Therapeutics initiated with a Buy at H.C. Wainwright


MapLight Therapeutics completes enrollment in ZEPHYR trial

2026-05-01T11:25:19.000Z - 2 months ago

MapLight Therapeutics completes enrollment in ZEPHYR trial


MapLight Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

MapLight Therapeutics Proxy statement: Proxy filing


MapLight Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

MapLight Therapeutics Proxy statement: Proxy filing


MapLight Therapeutics initiated with a Buy at Needham

2026-04-08T09:45:12.000Z - 3 months ago

MapLight Therapeutics initiated with a Buy at Needham


MapLight Therapeutics initiated with a Buy at TD Cowen

2026-04-07T09:41:31.000Z - 3 months ago

MapLight Therapeutics initiated with a Buy at TD Cowen


MapLight Therapeutics Annual report: Q4 2025

Mar 26, 2026, 7:00 AM EDT - 3 months ago

MapLight Therapeutics Annual report: Q4 2025


MapLight Therapeutics Earnings release: Q4 2025

Mar 26, 2026, 7:00 AM EDT - 3 months ago

MapLight Therapeutics Earnings release: Q4 2025


MapLight Therapeutics Slides: Corporate presentation

Mar 26, 2026, 7:00 AM EDT - 3 months ago

MapLight Therapeutics Slides: Corporate presentation


Canaccord starts MapLight with Buy into schizophrenia data

2026-03-19T10:40:48.000Z - 3 months ago

Canaccord starts MapLight with Buy into schizophrenia data


MapLight Therapeutics initiated with a Buy at Canaccord

2026-03-19T09:20:13.000Z - 3 months ago

MapLight Therapeutics initiated with a Buy at Canaccord


MapLight Therapeutics Transcript: Stifel 2026 Virtual CNS Forum

Mar 18, 2026, 6:00 PM EDT - 3 months ago

MapLight Therapeutics Transcript: Stifel 2026 Virtual CNS Forum


MapLight Therapeutics Slides: Corporate Presentation

Jan 9, 2026, 7:00 AM EST - 6 months ago

MapLight Therapeutics Slides: Corporate Presentation


MapLight Therapeutics Quarterly report: Q3 2025

Dec 4, 2025, 7:00 AM EST - 7 months ago

MapLight Therapeutics Quarterly report: Q3 2025


MapLight Therapeutics Earnings release: Q3 2025

Dec 4, 2025, 7:00 AM EST - 7 months ago

MapLight Therapeutics Earnings release: Q3 2025


MapLight Therapeutics Slides: Corporate Presentation

Dec 4, 2025, 7:00 AM EST - 7 months ago

MapLight Therapeutics Slides: Corporate Presentation


MapLight Therapeutics IPO Registration Document (S-1)

Sep 19, 2025, 4:11 PM EDT - 10 months ago

MapLight Therapeutics IPO Registration Document (S-1)


MapLight Therapeutics Registration statement: Registration Filing

Sep 19, 2025, 7:00 AM EDT - 10 months ago

MapLight Therapeutics Registration statement: Registration Filing


BioRich
BioRich Jul. 1 at 4:47 PM
$NNE Stocktwits Q2 Quarterly Filing: @BioRich Top 50 portfolio positions: 1) GUTS 2) ABVX 3) IBRX 4) ALT 5) KYTX 6) DAVE 7) CADL 8) MIST 9) UEC 10) OTLK 11) CAPR 12) TGTX 13) SABS 14) NVAX 15) LEGN 16) VKTX 17) OCUL 18) SOFI 19) BBIO 20) SGP 21) VNDA 22) SHAZ 23) NRXP 24) GPCR 25) EWTX 26) TLSA 27) SKM 28) MLTX 29) SNDX 30) JMIA 31) NKTR 32) VVOS 33) RGNX 35) ARRNF 36) CRMD 37) WVE 38) NUVB 39) SMMT 40) ANNX 41) CGON 42) TEM 43) IVA 44) PSN 45) LGND 46) $IMVT 47) $MPLT 48) NNE 49) $ARDX 50) $COGT If I own it, I believe in it. What am I missing? Hold too much? Not enough? Look forward to your feedback! Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers!
0 · Reply
Duncan_
Duncan_ Jun. 30 at 3:39 PM
0 · Reply
JuggernautRaider
JuggernautRaider Jun. 27 at 7:20 AM
$MPLT hmm tell me more? $CGTX $TLSA are golden and I own a bit of $BMY … Maplight is looking good. Really good 💡
1 · Reply
Duncan_
Duncan_ Jun. 26 at 4:03 PM
$MPLT as @BioRich says "lets make some money"
0 · Reply
Duncan_
Duncan_ Jun. 26 at 1:30 PM
0 · Reply
Hopipaytrader
Hopipaytrader Jun. 26 at 1:47 AM
$MPLT hello, getting close, but now up the ante
0 · Reply
Quantumup
Quantumup Jun. 25 at 1:14 PM
Raymond James y'day🏁 $MPLT and said: We are initiating coverage of MapLight Therapeutics (MPLT) at Strong Buy with a $46 target price. $BMY OTSKY ABBV NBIX LBRX RVPH ATAI TEVA ITCI Here's what Raymond James had to say: https://x.com/Quantumup1/status/2070133195882836133?s=20
0 · Reply
ripster47
ripster47 Jun. 25 at 11:12 AM
$MPLT | Raymond James Initiates MapLight Therapeutics at Strong Buy with $46.00 PT on Pipeline Differentiation and Clinical Upside Raymond James stays bullish as ML-007C-MA differentiation and mid-stage catalysts drive strong upside outlook 🔹 Follow @tenet_research for more analyst insights on other tickers.
0 · Reply
MNYMKR2018
MNYMKR2018 Jun. 25 at 12:30 AM
$MPLT Alright I’m sold! Follower 122! Reporting for duty…😜🍻
0 · Reply
Rearview
Rearview Jun. 24 at 9:57 PM
$MPLT CFO ”separated” due to HR violation - shortly after selling 1M holding
0 · Reply
Rearview
Rearview Jun. 24 at 9:55 PM
0 · Reply
BioRich
BioRich Jun. 24 at 4:29 PM
$MPLT @Duncan_ Welcome to the party Mr. #120. $MPLT is absolutely under the radar. Always a bit of a shock finding a ticker with such low followers. Off the top of my head, 3 others that stand out for jumping on early were $SHAZ, $SGP and $GUTS. Exciting times ahead! Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some (more) money. Cheers! $XBI
1 · Reply
Duncan_
Duncan_ Jun. 24 at 3:36 PM
$MPLT followers #120, still wayyyyy under the radar
1 · Reply
Quantumup
Quantumup Jun. 23 at 7:06 PM
Craig-Hallum⬇️ $MPLT-$40⬅️$43—reit-Buy—said—ML-004 Ph2 IRIS results were mixed but not thesis‍-breaking—missed 1° in social comm—but a meaningful benefit in a defined adolescent subgroup for irritability w/ >tolerability than existing APs $JNJ $BMY - OTSKY DFTX H.C. Wainwright reiterated MapLight Therapeutics Buy; $45 and here is what the analyst had to say: https://x.com/Quantumup1/status/2069496992699437443?s=20
0 · Reply
walkinghome
walkinghome Jun. 22 at 8:47 PM
$MPLT well tolerated meaningful improvement, also seb drugs in pip
0 · Reply
Astrobro
Astrobro Jun. 22 at 2:38 PM
$MPLT failed ph2 for ASD and still 1.3B MC?
1 · Reply
Duncan_
Duncan_ Jun. 22 at 2:10 PM
$MPLT Consistent with this, analysis of the clinician-rated CGI-I in the irritability domain for the same subpopulation demonstrated clinically meaningful improvement over placebo (effect size 1.08, nominal p=0.036). Treatment effects were greater among adolescents with greater levels of baseline irritability
1 · Reply
Duncan_
Duncan_ Jun. 22 at 1:45 PM
$MPLT green, any news?
1 · Reply
OpenOutcrier
OpenOutcrier Jun. 22 at 12:52 PM
$MPLT (-4.9% pre) MapLight’s autism drug trial misses primary endpoint https://ooc.bz/l/105705
0 · Reply
Camtanren
Camtanren Jun. 22 at 11:44 AM
$MPLT failed ?
0 · Reply
BioRich
BioRich Jun. 18 at 6:27 PM
$MPLT took advantage of the dip. See excellent long-term potential with short-term pops as they get more attention. Like $BBIO and $SGP.
0 · Reply
BioRich
BioRich Jun. 10 at 5:24 PM
$MPLT Excited to be follower #116. Push 900 by August/September?
3 · Reply